Labopharm sets U.S. joint venture with Italy’s Grupo Angelini
- April 29, 2010
Labopharm Inc. and Gruppo Angelini today announced they have entered into an agreement to establish a joint venture in the United States for the commercialization of OLEPTRO(TM), a novel once-daily formulation ... Read More